| An in vivo functional genetic screen reveals a role for the TRK-T3 oncogene in tumor progression. | None |
| Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein. | None |
| Oncogenic rearrangements of the NTRK1/NGF receptor. | None |
| Overexpression of human TRK proto-oncogene into mouse cells using an inducible vector system. | None |
| TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene. | None |
| Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. | None |
| Nerve growth factor binds to the 140 kd trk proto-oncogene product and stimulates its association with the src homology domain of phospholipase C gamma 1. | None |
| K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. | None |
| Phospholipase C-gamma 1 directly associates with the p70 trk oncogene product through its src homology domains. | None |
| The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31. | None |
| Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene. | None |
| The trk proto-oncogene encodes a receptor for nerve growth factor. | None |
| Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. | None |
| High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. | None |
| Results show that the TrkAIII oncogene promotes genetic instability by interacting with and exhibiting catalytic activity at the centrosome. | None |
| The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability. | None |
| Molecular mechanisms underlying NTRK1 oncogenic rearrangements, are discussed. | None |
| STAT3 has a role in in vitro transformation triggered by TRK oncogenes | None |
| Molecular characterization of human trk proto-oncogene product monoclonal antibodies. | None |
| Human TRK proto-oncogene maps to chromosome 1q32-q41. | None |